381 related articles for article (PubMed ID: 18843653)
1. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
Cochrane Database Syst Rev; 2008 Oct; (4):CD003989. PubMed ID: 18843653
[TBL] [Abstract][Full Text] [Related]
2. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
Cochrane Database Syst Rev; 2011 Jan; (1):CD003989. PubMed ID: 21249657
[TBL] [Abstract][Full Text] [Related]
3. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD003989. PubMed ID: 23904209
[TBL] [Abstract][Full Text] [Related]
4. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
[TBL] [Abstract][Full Text] [Related]
5. Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials.
Gallo MF; Nanda K; Grimes DA; Schulz KF
Contraception; 2005 Mar; 71(3):162-9. PubMed ID: 15722064
[TBL] [Abstract][Full Text] [Related]
6. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
7. Quadriphasic versus monophasic oral contraceptives for contraception.
Van Vliet HA; Raps M; Lopez LM; Helmerhorst FM
Cochrane Database Syst Rev; 2011 Nov; (11):CD009038. PubMed ID: 22071862
[TBL] [Abstract][Full Text] [Related]
8. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2013 Nov; (11):CD007541. PubMed ID: 24226383
[TBL] [Abstract][Full Text] [Related]
9. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
Zichella L; Sbrignadello C; Tomassini A; Di Lieto A; Montoneri C; Zarbo G; Mancone M; Pietrobattista P; Bertoli G; Perrone G
Adv Contracept; 1999; 15(3):191-200. PubMed ID: 11019950
[TBL] [Abstract][Full Text] [Related]
11. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2010 Jan; (1):CD007541. PubMed ID: 20091638
[TBL] [Abstract][Full Text] [Related]
12. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
Lopez LM; Grimes DA; Gallo MF; Stockton LL; Schulz KF
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD003552. PubMed ID: 23633314
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein AA; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Feb; (2):CD006586. PubMed ID: 22336820
[TBL] [Abstract][Full Text] [Related]
14. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2012 Apr; (4):CD006133. PubMed ID: 22513937
[TBL] [Abstract][Full Text] [Related]
15. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
[TBL] [Abstract][Full Text] [Related]
16. Triphasic versus monophasic oral contraceptives for contraception.
van Vliet HA; Grimes DA; Lopez LM; Schulz KF; Helmerhorst FM
Cochrane Database Syst Rev; 2006 Jul; (3):CD003553. PubMed ID: 16856013
[TBL] [Abstract][Full Text] [Related]
17. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.
Edelman AB; Gallo MF; Jensen JT; Nichols MD; Schulz KF; Grimes DA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004695. PubMed ID: 16034942
[TBL] [Abstract][Full Text] [Related]
18. Types of progestogens in combined oral contraception: effectiveness and side-effects.
Lawrie TA; Helmerhorst FM; Maitra NK; Kulier R; Bloemenkamp K; Gülmezoglu AM
Cochrane Database Syst Rev; 2011 May; (5):CD004861. PubMed ID: 21563141
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
Endrikat J; Düsterberg B; Ruebig A; Gerlinger C; Strowitzki T
Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
[TBL] [Abstract][Full Text] [Related]
20. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
